A 2026 update highlights ongoing clinical trials in β-thalassemia, providing insights into emerging therapies and their potential impact on patient outcomes. This update is crucial for stakeholders monitoring advancements in treatment options for this rare blood disorder.
2026 update on clinical trials in thalassemia
Original title: “2026 Update on Clinical Trials in β-Thalassemia.”